Reproductive number of COVID-19: A systematic review and meta-analysis based on global level evidence
=====================================================================================================
* Md. Arif Billah
* Md. Mamun Miah
* Md. Nuruzzaman Khan
## Abstract
**Background** The coronavirus (COVID-19) is now a global concern because of its higher transmission capacity and associated adverse consequences including death. The reproductive number of COVID-19 provides an estimate on possible extent of the transmission. This study aims to provide the average reproductive number of COVID-19 based on available global level evidence.
**Methods** We searched three databases (PubMed, Web of Science, and Science Direct) to find studies reported the reproductive number of COVID-19. The searches were conducted using a pre-specified search strategy that includes keywords of COVID-19 and its reproductive number related terms, which were combined using the Boolean operators. We used meta-analysis to provide average reproduction number of COVID-19.
**Results** Total of 30 studies included in this review whereas 24 of them were included in the meta-analysis. The average estimated reproductive number was 2.70 (95% CI, 2.21-3.30). We found evidence of very high heterogeneity (99.5%) of the reproductive number reported in the included studies. The highest reproductive number was reported for Diamond Princes Cruise Ship, Japan (14.8). In the country-level, higher reproductive number was reported for France (R, 6.32, 95% CI, 5.72-6.98) following Germany (R, 6.07, 95% CI, 5.51-6.69) and Spain (R, 5.08, 95% CI, 4.50-5.73). We also found estimation models, methods, and the number of cases considered to estimate reproductive number were played a role in arising the heterogeneity of the estimated reproductive number.
**Conclusion** The estimated reproductive number indicates an exponential increase of COVID-19 infection in coming days. Comprehensive policies and programs are important to reduce new infections as well as the associated adverse consequences including death.
Keywords
* Coronavirus (COVID-19)
* Reproductive number
* systematic review
* meta-analysis
## Background
Coronavirus (COVID-19) is now a global concern that speared out to 213 countries or territories as of May 30, 2020. More than 6 million population have been infected so far worldwide, of which more than 367,304 are died [1]. Consequently, the World Health Organization has declared it as pandemic and suggested countries to take aggressive measures to reduce new infections [2]. Given no treatments or vaccines available for this virus, countries are now also taking numerous non-medical measures to reduce further infections, which include restricting people’s movements, banned international and local travels, quarantine, and isolation [3]. However, the new infections are rising exponentially, in all ages and sexes, irrespective of countries [4,5]. Reducing new infections, therefore, needs further comprehensive preventive measures.
The virus was first discovered by Tyrrell and Bynoe in 1965 in the human respiratory tract of an adult infected with the common cold [6]. Since then the virus caused three major large-scale outbreaks, namely, Severe Acute Respiratory Syndrome (SARS) in 2003 in mainland China [7], Middle East Respiratory Syndrome (MERS) in 2012 in Saudi-Arabia [8], and MERS in 2015 in South Korea [9]. These outbreaks showed some similar characteristics which are common with current COVID-19 outbreak, such as fever, cough, and the breathing difficulties [10].
This round of coronavirus appeared from a single center in a seafood market of Wuhan, China [11]. Two families consisting of five people or healthcare workers infected initially from the seafood market and visited a nearest healthcare center, from where the virus was spread rapidly to other people (nosocomial) through human-to-human transmission [12-16]. The virus then spread out worldwide through international travelers from China (Figure 1) [17].
[Figure 1:](http://medrxiv.org/content/early/2020/05/31/2020.05.23.20111021/F1)
Figure 1:
The probable ways of the COVID-19 transmission into the human and turned into a person-to-person transmission process (The seafood shop was the center from where the virus transmitted into customers or sellers or both. The symptoms of the infection were normal cold, headache, and pneumonia. The infected persons then transmitted the virus to non-infected in two different routes: (a). Infected persons went to the nearby hospital for treatment. Clinical manifestations were not examined properly and the infected persons presented risk to transmission among non-infected hospital attendances (b). Infection also transmitted into the infected person family members. The virus was then spread out worldwide, at the end of February 2020, through the infected international travelers from China).
Knowing the accurate reproductive number of COVID-19, which means the capability of transmission per primary infected person to the secondarily infected persons, is significant for various reasons: to assess epidemic transmissibility and to predict the future trend of spreading [18]. These are important to reduce new infections and to design control measures such as social distancing [19] and to know the duration of keeping control measures [5]. Moreover, it also helps to develop an effective epidemiological mathematical models considering possible transmission ways, such as, droplets and direct contacts with COVID-19 infected people, which are important to know the risk population and the appropriate epidemiologic parameters [20,21].
Various researchers worldwide estimated reproductive number of COVID-19. However, these were not consistent and measurement procedures and methods were different across the studies [20,22]. The reproductive number estimated was also found different across the countries, stages of infection, and the preventive measures applied [23]. Another important source of variation of estimated reproductive number was type of reproductive numbers considered [20]. Of the three reproductive numbers estimated, namely basic reproductive number (*R*), net reproductive number (*Re*), and time dependent reproductive number (*Rt*), are applicable for different purposes. For instance, the basic reproductive number is used when an infected person can mix randomly to non-infected persons (i.e no control intervention was applied), whereas, the net and time-dependent reproductive number are used when control interventions were applied. Consequently, these three reproductive numbers are also followed different distributions of infection period. However, the value of each reproductive number ranges from zero to any positive number, where *R* < 1 indicates new infection will decrease, *R* < 0 indicates the stability of new infection, and *R* < 1 indicates new infection will increase [24,25].
Considering the higher variability of the reproductive number estimated and its underlying importance, in this study, an attempt has been made to summarize available reproductive number of COVID-19 to give an average estimate. If applicable, sources of variations of the estimated reproductive number will also be addressed. Findings will help policymakers to know about the possible increase of COVID-19’s patients and take policies and programs accordingly.
## Methods
Literature searches were conducted in three databases on April 10, 2020: PubMed, Web of Science, and Science Direct. The pre-specified search strategies were used to search databases (Supplementary Tables 1-3). We developed search strategies consisting of virus-specific (corona virus, coronavirus, SARS-CoV-2, COVID-19, nCoV-2019) and reproductive number related (reproduction number, transmissibility) keywords that were combined using the Boolean operators (AND, OR). Additional searches were conducted in the reference list of the selected articles, and the relevant journal’s websites.
View this table:
[Supplemental Table 1.](http://medrxiv.org/content/early/2020/05/31/2020.05.23.20111021/T4)
Supplemental Table 1. Web of science search results for pre-existing morbidities among COVID-19 patients
View this table:
[Supplemental Table 2.](http://medrxiv.org/content/early/2020/05/31/2020.05.23.20111021/T5)
Supplemental Table 2. Science Direct search results for reproductive number of COVID-19
View this table:
[Supplemental Table 3.](http://medrxiv.org/content/early/2020/05/31/2020.05.23.20111021/T6)
Supplemental Table 3. PUBMED search results for reproductive number of COVID-19
### Inclusion and exclusion criteria
Studies meet the following inclusion criteria were included: wrote in the English language, related to COVID-19, and presented the reproductive number of COVID-19. We did not apply any time restriction, i.e. all studies from the onset of COVID-19 to the date of conducting formal search were included. Studies that did not meet these criteria were excluded.
### Data extraction and analysis
Two authors (MAB, MMM) extracted information by using a pre-designed, trailed, and modified data extraction sheet. The extracted information includes: year of publication, study’s location, model used to estimate the reproductive number, time period for when the reproductive number was estimated, number of cases considered to estimate the reproductive number, assumption(s) that was/were set to a calculate the reproductive number, intervention strategy, and the estimated reproductive number with its 95% confidence interval (CI). The corresponding author (MNK) solved any disagreement on information extraction.
The information recorded were mostly dichotomous in nature where the numerical reproductive number was reported in all selected studies. We, therefore, used both narrative synthesis and meta-analysis to summaries findings from retrieved studies. Narrative synthesis used initially to describe assumptions applied in estimating the reproductive number, number of cases used to estimate reproductive number, time/period for when the reproductive number estimated, and the models and methods used to estimate the reproductive number. Meta-analysis then used to give an average estimate of the reproductive number. We used both fixed effect and random effect model to summarize the reproductive number selected based on heterogeneity assessment (*I2*). We used fixed effect model if the heterogeneity was low (*I*2 < 50%) and the random effect model if the heterogeneity was moderate (*I*2 < 50%) or high (*I*2 < 75%). For the studies where more than one reproductive number reported based on different assumptions, we calculated the average reproductive number. This calculated average reproductive number was then used to give summary estimate of the reproductive number. Heterogeneity of the average estimated reproductive number was assessed through sub-groups analysis across the selected studies’ characteristics. We also assessed the publication bias through visual inspection of the funnel plot and Egger’s regression asymmetry test. Trim-and-Fill procedure was used when evidence of publication bias was found. The National Institutes of Health (NIH) study quality assessment tool was used to assess study quality. The Stata software version 15.1 (Stata Corp, College Station, Texas, USA) was used to perform all analyses.
## Results
### Literature search results
Total of 134 studies included, 130 of them were extracted from three databases searched (Figure 2, Supplementary Tables 1-3). Of these, 102 studies were excluded through title and abstract screening leaving 32 studies for full-text review. A total of 30 of them were finally included in this study and 24 of them were included in meta-analysis. All study were high in quality (Supplementary Table 4).
View this table:
[Supplemental Table 4.](http://medrxiv.org/content/early/2020/05/31/2020.05.23.20111021/T7)
Supplemental Table 4. Assessment of the included study through the NIH assessment tool
View this table:
[Table8](http://medrxiv.org/content/early/2020/05/31/2020.05.23.20111021/T8)
View this table:
[Table9](http://medrxiv.org/content/early/2020/05/31/2020.05.23.20111021/T9)
[Figure 2.](http://medrxiv.org/content/early/2020/05/31/2020.05.23.20111021/F2)
Figure 2.
Schematic representation of studies included in the systematic review using the PRISMA checklist and flow diagram
Majority of the studies selected were conducted in China (8) [18,26–32] and its province (6) [33–38]. The remaining studies were conducted in Japan (4) [39–42] followed by South Korea (3) [43–45], Italy (2) [46,47], and France, Germany, and Spain [47]. Four studies included were conducted based on multiple countries’ data [19,48–50].
### Estimated reproduction number
Of the 30 studies included in this review reported different reproductive numbers (Table 1). The estimated reproductive number in this analysis was 2.70 (95% CI, 2.21-3.30) with a very high-heterogeneity (99.5%) (Figure 3). However, we did not find any evidence of publication bias (Supplementary Figure 1). Sub-group analysis was used to address heterogeneity (Table 2, Supplementary Figures 2-5). We found study’s characteristics, such as countries for which the reproductive number estimated, models and methods used to estimate the reproductive number, and the number of cases used to estimate reproductive number were played a significant role of arising such heterogeneity (Table 2). For instance, the estimated reproductive number was around double (R, 4.56, 95% CI, 2.28-9.12) in outside of China than China (R, 2.72, 95% CI, 2.08-3.57). However, in the country level, the highest reproductive number was reported for France (R, 6.32, 95% CI, 5.72-6.98) following Germany (R, 6.07, 95% CI, 5.51-6.69) and Spain (R, 5.08, 95% CI, 4.50-5.73). South Korea was only country reported <1 reproductive number of COVID-19 (R, 0.76, 95% CI, 0.34-1.70). The higher reproductive number was reported if estimated by the MCMC method (R, 4.18, 95% CI, 1.75-9.93) and by the Epidemic curve model (R, 2.86, 95% CI, 2.39-3.42). The average reproductive number found higher if it was estimated for >3162 cases (R, 2.97, 95% CI, 2.09-4.23) than ≤3162 cases (R, 2.50, 95% CI, 1.91-3.28).
[Supplementary Figure 1:](http://medrxiv.org/content/early/2020/05/31/2020.05.23.20111021/F4)
Supplementary Figure 1: Funnel plot for the included studies estimated reproductive number of COVID-19 to identify publication bias
[Supplementary Figure 2:](http://medrxiv.org/content/early/2020/05/31/2020.05.23.20111021/F5)
Supplementary Figure 2: Estimated reproductive number of COVID-19 across countries
[Supplementary Figure 3:](http://medrxiv.org/content/early/2020/05/31/2020.05.23.20111021/F6)
Supplementary Figure 3: Estimated reproductive number of COVID-19 across methods used to estimate
[Supplementary Figure 4:](http://medrxiv.org/content/early/2020/05/31/2020.05.23.20111021/F7)
Supplementary Figure 4: Estimated reproductive number of COVID-19 across models used to estimate
[Supplementary Figure 5:](http://medrxiv.org/content/early/2020/05/31/2020.05.23.20111021/F8)
Supplementary Figure 5: Estimated reproductive number of COVID-19 across the number of cases considered to estimate
View this table:
[Table 1:](http://medrxiv.org/content/early/2020/05/31/2020.05.23.20111021/T1)
Table 1: Background characteristics of the studies included in this review
[Figure 3:](http://medrxiv.org/content/early/2020/05/31/2020.05.23.20111021/F3)
Figure 3:
Summarized reproductive number of COVID-19 (total 24 studies with 27 times report of COVID-19’s reproductive number [one study (Yuan et al., 2020) reported estimates for four different countries])
View this table:
[Table 2:](http://medrxiv.org/content/early/2020/05/31/2020.05.23.20111021/T2)
Table 2: Sources of heterogeneity of the estimated COVID-19’s reproductive number
The results of the narrative synthesis are presented in Table 3. Total of six studies were narratively synthesized. The findings of these six studies also supported our summary estimate. A study conducted for Diamond Princes Cruise Ship, Japan found reproductive number of COVID-19 was 14.8 for the period of 21 January to 19 February 2020 [41]. However, this estimated reproductive number was conditioned for not to applied any preventive intervention and infected person can mix randomly to the non-infected persons. When preventive interventions applied this number was reduced to 1.78.
View this table:
[Table 3:](http://medrxiv.org/content/early/2020/05/31/2020.05.23.20111021/T3)
Table 3: Narrative synthesis of the studies included in in review
## Discussion
This review aimed to provide the reproductive number of COVID-19 based on the global level evidence. A total of 30 studies selected for this study of which 24 studies were included in the meta-analysis. Majority of the included studies were conducted in China. The average estimated reproductive number was 2.70 with evidence of higher heterogeneity across the included studies. The sources of heterogeneity were countries for which the reproductive number estimated, models and methods used to estimate the reproductive number, and the number of cases used to estimate the reproductive number.
The average estimated reproductive number was 2.7; which is higher than the WHO’s estimate of 1. 4 to 2.5. However, this estimate is lower than the previous summarized reproductive number of COVID-19 (3.28) [54]. Numerous measures to reduce new infections of COVID-19 such as social distancing, and controlling international travels are associated with such reduction [17,55]. However, our estimated reproductive number is still very high that leads an exponential increase of new infections. Moreover, the estimated number is still very higher than previous rounds of COVID-19’s like infectious diseases, such as SARS and MERS if we considered time period between the when was estimation done and infections was initially detected. For instance, the reproductive number of SARS and MERS were reduced to 0.95 (95% CI, 0.61-1,23) and 0.91 (95% CI, 0.36-1.44) after 3rd generation of the infection [56]. There are numerous reasons for such a higher reproductive number. First, biological facts of the infection rate and duration of contagion are important to explain such higher reproductive number instead of strict control measures that placed to reduce new infections [57]. For instance, a person could be infected in numerous ways, such as gets physically contacted with the infected person or through environmental transmission by respiratory droplets [58]. Moreover, COVID-19 infected patients may not show symptomatic characteristics up to two weeks of infection. This pre-symptomatic stage is another source to increase new infections exponentially as in this period an infected person is usually confounded in the community with other people. This risk is further increased significantly for the country where population density is high [59].
This study also found evidence of the very high (99.5%) heterogeneity of the estimated reproductive number. Along with the factors described above, characteristics used to estimate reproductive numbers are important source for such heterogeneity. For instance, the reproductive number found higher for the countries where no restriction was applied or restriction was applied in delayed. The forms of restrictions were control people’s movement, personal hygiene, and wearing mask [10,60]. These implications act to control virus transmission from an infected to the susceptible and reduce the new infections. These also affect the average transmissibility of COVID-19 within the specific population and settings [61,62].
Estimation models, assumptions applied, and estimation processes were empirical sources of variability of the estimated COVID-19’s reproductive number [63]. For instance, studies included in this analysis were followed assumption of generation time (which is followed by the gamma distribution) or serial interval (which is followed by the poison distribution) which is an important source of heterogeneity [64–66]. The reason of such difference is the underlying concept: generation time refers to the average time between transmission the virus from an infected person to the non-infected person whereas serial interval refers duration between onset of symptoms in an index case to the transmission in a secondary case [64,65,67]. Moreover, the estimated reproduction number generated by mathematical models is dependent on numerous decisions made by the researcher such as homogeneity or heterogeneity of the population considered; use a deterministic or stochastic approach and which distributions to be used to describe the probable values of parameters [57].
This study was first of its kind that provides an estimation of reproductive numbers based on worldwide’ literature. Moreover, we have considered the heterogeneity of the reproductive numbers estimated worldwide and explored the sources of heterogeneity across selected studies’ characteristics. However, many other factors may explain the sources of heterogeneity of the reported reproductive number of COVID-19 worldwide. We did not explore these because of the lack of data.
## Conclusion
The average estimated reproductive number was 2.70. We found evidence of higher heterogeneity of the reproductive number reported worldwide. There are numerous causes of such heterogeneity, however, study related characteristics were countries for which the reproductive number estimated, methods and models used to estimate reproductive number, and the number of cases considered to estimate reproductive number. This analysis indicates possibility to significant increase of COVID-19 infections in the coming days. Strengthing existing preventive measures as well as new policies and programs are important to reduce new infections.
## Data Availability
Data available on request to the corresponding author
## Conflict of interest
There is no conflict of interest.
## Funds
This study did not received any financial support.
## Ethical approval
Ethical approval was not necessary for this kind of study.
: Abbreviations
COVID-19
: Novel Coronavirus 2019
EGR
: Exponential Growth Rate
MCMC
: Markov Chain Monte Carlo
MERS
: Middle East Respiratory Syndrome
MLE
: Maximum Likelihood Estimation
SARS
: Severe Acute Respiratory Syndrome
SEIR
: Susceptible, Exposed, Infected and Removed/Recovered
SIR
: Susceptible, Infected and Removed/Recovered
## Acknowledgment
The authors are grateful to the authors of the paper included in this review.
* Received May 23, 2020.
* Revision received May 30, 2020.
* Accepted May 31, 2020.
* © 2020, Posted by Cold Spring Harbor Laboratory
This pre-print is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), CC BY-NC 4.0, as described at [http://creativecommons.org/licenses/by-nc/4.0/](http://creativecommons.org/licenses/by-nc/4.0/)
## References
1. 1.Coronavirus Update (Live) - Worldometer. In: Worldometer [Internet]. [cited 22 May 2020]. Available: [https://www.worldometers.info/coronavirus/](https://www.worldometers.info/coronavirus/)
2. 2.WHO. Novel Coronavirus(2019-nCoV) Situation Report - 10. World Health Organization; 2020 Jan p. 7. Report No.: 10. Available: [https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200130-sitrep-10-ncov.pdf?sfvrsn=d0b2e480_2](https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200130-sitrep-10-ncov.pdf?sfvrsn=d0b2e480_2)
3. 3.Mohamed AA, Mohamed N, Mohamoud S, Zahran FE, Khattab RA, El-Damasy DA, et al. SARS-CoV-2: The Path of Prevention and Control. Infect Disord - Drug Targets. 2020;20. doi:10.2174/1871526520666200520112848
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.2174/1871526520666200520112848&link_type=DOI)
4. 4.Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 2020;395: 507–513. doi:10.1016/S0140-6736(20)30211-7
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/S0140-6736(20)30211-7&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=32007143&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F05%2F31%2F2020.05.23.20111021.atom)
5. 5.Chen X, Yu B. First two months of the 2019 Coronavirus Disease (COVID-19) epidemic in China: real-time surveillance and evaluation with a second derivative model. Glob Health Res Policy. 2020;5: 7. doi:10.1186/s41256-020-00137-4
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1186/s41256-020-00137-4&link_type=DOI)
6. 6.Kahn JS, McIntosh K. History and Recent Advances in Coronavirus Discovery: Pediatr Infect Dis J. 2005;24: S223–S227. doi:10.1097/01.inf.0000188166.17324.60
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1097/01.inf.0000188166.17324.60&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=16378050&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F05%2F31%2F2020.05.23.20111021.atom)
7. 7.Zhong NS, Zheng BJ, Li YM, Poon null, Xie ZH, Chan KH, et al. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People’s Republic of China, in February, 2003. Lancet Lond Engl. 2003;362: 1353–1358. doi:10.1016/s0140-6736(03)14630-2
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/s0140-6736(03)14630-2&link_type=DOI)
8. 8.Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus ADME, Fouchier RAM. Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia. N Engl J Med. 2012;367: 1814–1820. doi:10.1056/NEJMoa1211721
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1056/NEJMoa1211721&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=23075143&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F05%2F31%2F2020.05.23.20111021.atom)
[Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000310773200008&link_type=ISI)
9. 9.Cowling BJ, Park M, Fang VJ, Wu P, Leung GM, Wu JT. Preliminary epidemiological assessment of MERS-CoV outbreak in South Korea, May to June 2015. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull. 2015;20: 7–13. doi:10.2807/1560-7917.es2015.20.25.21163
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.2807/1560-7917.es2015.20.25.21163&link_type=DOI)
10. 10.Adhikari SP, Meng S, Wu Y-J, Mao Y-P, Ye R-X, Wang Q-Z, et al. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infect Dis Poverty. 2020;9. doi:10.1186/s40249-020-00646-x
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1186/s40249-020-00646-x&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F05%2F31%2F2020.05.23.20111021.atom)
11. 11.Jiang S, Du L, Shi Z. An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies. Emerg Microbes Infect. 2020;9: 275–277. doi:10.1080/22221751.2020.1723441
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1080/22221751.2020.1723441&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=32005086&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F05%2F31%2F2020.05.23.20111021.atom)
12. 12.Chan JF-W, Yuan S, Kok K-H, To KK-W, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. The Lancet. 2020;395: 514–523. doi:10.1016/S0140-6736(20)30154-9
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/S0140-6736(20)30154-9&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=31986261&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F05%2F31%2F2020.05.23.20111021.atom)
13. 13.Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA. 2020;323: 1061. doi:10.1001/jama.2020.1585
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1001/jama.2020.1585&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=32031570&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F05%2F31%2F2020.05.23.20111021.atom)
14. 14.Wu F, Zhao S, Yu B, Chen Y-M, Wang W, Song Z-G, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579: 265–269. doi:10.1038/s41586-020-2008-3
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1038/s41586-020-2008-3&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=32015508&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F05%2F31%2F2020.05.23.20111021.atom)
15. 15.Wu P, Hao X, Lau EHY, Wong JY, Leung KSM, Wu JT, et al. Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020. Eurosurveillance. 2020;25. doi:10.2807/1560-7917.ES.2020.25.3.2000044
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.2807/1560-7917.ES.2020.25.3.2000044&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=31992388&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F05%2F31%2F2020.05.23.20111021.atom)
16. 16.Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 [cited 18 Mar 2020]. doi:10.1001/jama.2020.2648
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1001/jama.2020.2648&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=32091533&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F05%2F31%2F2020.05.23.20111021.atom)
17. 17.Zhong P, Guo S, Chen T. Correlation between travellers departing from Wuhan before the Spring Festival and subsequent spread of COVID-19 to all provinces in China. J Travel Med. 2020;27. doi:10.1093/jtm/taaa036
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1093/jtm/taaa036&link_type=DOI)
18. 18.Zhou T, Liu Q, Yang Z, Liao J, Yang K, Bai W, et al. Preliminary prediction of the basic reproduction number of the Wuhan novel coronavirus 2019-nCoV. J Evid-Based Med. 2020;13: 3–7. doi:10.1111/jebm.12376
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1111/jebm.12376&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=32048815&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F05%2F31%2F2020.05.23.20111021.atom)
19. 19.Riou J, Althaus CL. Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020. Eurosurveillance. 2020;25. doi:10.2807/1560-7917.ES.2020.25.4.2000058
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.2807/1560-7917.ES.2020.25.4.2000058&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=32019669&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F05%2F31%2F2020.05.23.20111021.atom)
20. 20.Heesterbeek JAP, Roberts MG. The type-reproduction number T in models for infectious disease control. Math Biosci. 2007;206: 3–10. doi:10.1016/j.mbs.2004.10.013
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.mbs.2004.10.013&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=16529777&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F05%2F31%2F2020.05.23.20111021.atom)
[Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000245717200002&link_type=ISI)
21. 21.Swerdlow DL, Finelli L. Preparation for Possible Sustained Transmission of 2019 Novel Coronavirus: Lessons From Previous Epidemics. JAMA. 2020 [cited 18 Mar 2020]. doi:10.1001/jama.2020.1960
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1001/jama.2020.1960&link_type=DOI)
22. 22.Heffernan JM, Smith RJ, Wahl LM. Perspectives on the basic reproductive ratio. J R Soc Interface. 2005;2: 281–293. doi:10.1098/rsif.2005.0042
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1098/rsif.2005.0042&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=16849186&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F05%2F31%2F2020.05.23.20111021.atom)
[Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000234342000002&link_type=ISI)
23. 23.Woolhouse M. Quantifying Transmission. In: Baquero F, Bouza E, Gutiérrez-Fuentes JA, Coque TM, editors. Microbial Transmission. Washington, DC, USA: ASM Press; 2019. pp. 279–289. doi:10.1128/9781555819743.ch16
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1128/9781555819743.ch16&link_type=DOI)
24. 24.Li MY. An Introduction to Mathematical Modeling of Infectious Diseases. Cham: Springer International Publishing; 2018. doi:10.1007/978-3-319-72122-4
25. 25.Vynnycky E, White RG. An introduction to infectious disease modelling. New York: Oxford University Press; 2010.
26. 26.Imai N, Cori A, Dorigatti I, Baguelin M, Donnelly CA, Riley S. Report 3: Transmissibility of 2019-nCoV. 2020; 5.
27. 27.Sanche S, Lin YT, Xu C, Romero-Severson E, Hengartner N, Ke R. High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2. Emerg Infect Dis. 2020;26. doi:10.3201/eid2607.200282
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.3201/eid2607.200282&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=32255761&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F05%2F31%2F2020.05.23.20111021.atom)
28. 28.Song QQ, Zhao H, Fang LQ, Liu W, Zheng C, Zhang Y. Study on assessing early epidemiological parameters of COVID-19 epidemic in China. Zhonghua Liu Xing Bing Xue Za Zhi Zhonghua Liuxingbingxue Zazhi. 2020;41: 461–465. doi:10.3760/cma.j.cn112338-20200205-00069
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.3760/cma.j.cn112338-20200205-00069&link_type=DOI)
29. 29.Tang B, Wang X, Li Q, Bragazzi NL, Tang S, Xiao Y, et al. Estimation of the Transmission Risk of the 2019-nCoV and Its Implication for Public Health Interventions. J Clin Med. 2020;9: 462. doi:10.3390/jcm9020462
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.3390/jcm9020462&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=32046137&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F05%2F31%2F2020.05.23.20111021.atom)
30. 30.Zhao S, Lin Q, Ran J, Musa SS, Yang G, Wang W, et al. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak. Int J Infect Dis. 2020;92: 214–217. doi:10.1016/j.ijid.2020.01.050
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.ijid.2020.01.050&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=32007643&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F05%2F31%2F2020.05.23.20111021.atom)
31. 31.Zhao S, Musa SS, Lin Q, Ran J, Yang G, Wang W, et al. Estimating the Unreported Number of Novel Coronavirus (2019-nCoV) Cases in China in the First Half of January 2020: A Data-Driven Modelling Analysis of the Early Outbreak. J Clin Med. 2020;9: 388. doi:10.3390/jcm9020388
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.3390/jcm9020388&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=32024089&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F05%2F31%2F2020.05.23.20111021.atom)
32. 32.Zhou W, Wang A, Xia F, Xiao Y, Tang S. Effects of media reporting on mitigating spread of COVID-19 in the early phase of the outbreak. Math Biosci Eng. 2020;17: 2693–2707. doi:10.3934/mbe.2020147
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.3934/mbe.2020147&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=32233561&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F05%2F31%2F2020.05.23.20111021.atom)
33. 33.Chen T-M, Rui J, Wang Q-P, Zhao Z-Y, Cui J-A, Yin L. A mathematical model for simulating the phase-based transmissibility of a novel coronavirus. Infect Dis Poverty. 2020;9: 24. doi:10.1186/s40249-020-00640-3
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1186/s40249-020-00640-3&link_type=DOI)
34. 34.Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia. N Engl J Med. 2020; NEJMoa2001316. doi:10.1056/NEJMoa2001316
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1056/NEJMoa2001316&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=31995857&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F05%2F31%2F2020.05.23.20111021.atom)
35. 35.Majumder M, Mandl KD. Early Transmissibility Assessment of a Novel Coronavirus in Wuhan, China. SSRN Electron J. 2020 [cited 12 May 2020]. doi:10.2139/ssrn.3524675
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.2139/ssrn.3524675&link_type=DOI)
36. 36.Shen M, Peng Z, Xiao Y, Zhang L. Modelling the epidemic trend of the 2019 novel coronavirus outbreak in China. Microbiology; 2020 Jan. doi:10.1101/2020.01.23.916726
[Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NzoiYmlvcnhpdiI7czo1OiJyZXNpZCI7czoxOToiMjAyMC4wMS4yMy45MTY3MjZ2MSI7czo0OiJhdG9tIjtzOjUwOiIvbWVkcnhpdi9lYXJseS8yMDIwLzA1LzMxLzIwMjAuMDUuMjMuMjAxMTEwMjEuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9)
37. 37.Wan K, Chen J, Lu C, Dong L, Wu Z, Zhang L. When will the battle against novel coronavirus end in Wuhan: A SEIR modeling analysis. J Glob Health. 2020;10: 011002. doi:10.7189/jogh.10.011002
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.7189/jogh.10.011002&link_type=DOI)
38. 38.Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. The Lancet. 2020;395: 689–697. doi:10.1016/S0140-6736(20)30260-9
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/S0140-6736(20)30260-9&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=32014114&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F05%2F31%2F2020.05.23.20111021.atom)
39. 39.Kuniya T. Prediction of the Epidemic Peak of Coronavirus Disease in Japan, 2020. J Clin Med. 2020;9: 789. doi:10.3390/jcm9030789
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.3390/jcm9030789&link_type=DOI)
40. 40.Mizumoto K, Chowell G. Transmission potential of the novel coronavirus (COVID-19) onboard the diamond Princess Cruises Ship, 2020. Infect Dis Model. 2020;5: 264–270. doi:10.1016/j.idm.2020.02.003
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.idm.2020.02.003&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=32190785&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F05%2F31%2F2020.05.23.20111021.atom)
41. 41.Rocklöv J, Sjödin H, Wilder-Smith A. COVID-19 outbreak on the Diamond Princess cruise ship: estimating the epidemic potential and effectiveness of public health countermeasures. J Travel Med. 2020; taaa030. doi:10.1093/jtm/taaa030
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1093/jtm/taaa030&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=32109273&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F05%2F31%2F2020.05.23.20111021.atom)
42. 42.Zhang S, Diao M, Yu W, Pei L, Lin Z, Chen D. Estimation of the reproductive number of novel coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: A data-driven analysis. Int J Infect Dis. 2020;93: 201–204. doi:10.1016/j.ijid.2020.02.033
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.ijid.2020.02.033&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=32097725&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F05%2F31%2F2020.05.23.20111021.atom)
43. 43.Choi S, Ki M. Estimating the reproductive number and the outbreak size of COVID-19 in Korea. Epidemiol Health. 2020;42: e2020011. doi:10.4178/epih.e2020011
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.4178/epih.e2020011&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=32164053&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F05%2F31%2F2020.05.23.20111021.atom)
44. 44.Ki M. Epidemiologic characteristics of early cases with 2019 novel coronavirus (2019-nCoV) disease in Korea. Epidemiol Health. 2020;42: e2020007. doi:10.4178/epih.e2020007
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.4178/epih.e2020007&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F05%2F31%2F2020.05.23.20111021.atom)
45. 45.Shim E, Tariq A, Choi W, Lee Y, Chowell G. Transmission potential and severity of COVID-19 in South Korea. Int J Infect Dis. 2020;93: 339–344. doi:10.1016/j.ijid.2020.03.031
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.ijid.2020.03.031&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F05%2F31%2F2020.05.23.20111021.atom)
46. 46.D’Arienzo M, Coniglio A. Assessment of the SARS-CoV-2 basic reproduction number, R0, based on the early phase of COVID-19 outbreak in Italy. Biosaf Health. 2020; S2590053620300410. doi:10.1016/j.bsheal.2020.03.004
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.bsheal.2020.03.004&link_type=DOI)
47. 47.Yuan J, Li M, Lv G, Lu ZK. Monitoring Transmissibility and Mortality of COVID-19 in Europe. Int J Infect Dis. 2020 [cited 11 May 2020]. doi:10.1016/j.ijid.2020.03.050
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.ijid.2020.03.050&link_type=DOI)
48. 48.Kucharski AJ, Russell TW, Diamond C, Liu Y, Edmunds J, Funk S, et al. Early dynamics of transmission and control of COVID-19: a mathematical modelling study. Lancet Infect Dis. 2020; S1473309920301444. doi:10.1016/S1473-3099(20)30144-4
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/S1473-3099(20)30144-4&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=32171059&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F05%2F31%2F2020.05.23.20111021.atom)
49. 49.Liu T, Hu J, Xiao J, He G, Kang M, Rong Z, et al. Time-varying transmission dynamics of Novel Coronavirus Pneumonia in China. Systems Biology; 2020 Jan. doi:10.1101/2020.01.25.919787
[Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NzoiYmlvcnhpdiI7czo1OiJyZXNpZCI7czoxOToiMjAyMC4wMS4yNS45MTk3ODd2MiI7czo0OiJhdG9tIjtzOjUwOiIvbWVkcnhpdi9lYXJseS8yMDIwLzA1LzMxLzIwMjAuMDUuMjMuMjAxMTEwMjEuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9)
50. 50.Read JM, Bridgen JR, Cummings DA, Ho A, Jewell CP. Novel coronavirus 2019-nCoV: early estimation of epidemiological parameters and epidemic predictions. Infectious Diseases (except HIV/AIDS); 2020 Jan. doi:10.1101/2020.01.23.20018549
[Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NzoibWVkcnhpdiI7czo1OiJyZXNpZCI7czoyMToiMjAyMC4wMS4yMy4yMDAxODU0OXYyIjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjAvMDUvMzEvMjAyMC4wNS4yMy4yMDExMTAyMS5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=)
51. 51.Lai A, Bergna A, Acciarri C, Galli M, Zehender G. Early phylogenetic estimate of the effective reproduction number of SARS-CoV-2. J Med Virol. 2020;92: 675–679. doi:10.1002/jmv.25723
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1002/jmv.25723&link_type=DOI)
52. 52.Jung S, Akhmetzhanov AR, Hayashi K, Linton NM, Yang Y, Yuan B, et al. Real-Time Estimation of the Risk of Death from Novel Coronavirus (COVID-19) Infection: Inference Using Exported Cases. J Clin Med. 2020;9: 523. doi:10.3390/jcm9020523
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.3390/jcm9020523&link_type=DOI)
53. 53.Iwata K, Miyakoshi C. A Simulation on Potential Secondary Spread of Novel Coronavirus in an Exported Country Using a Stochastic Epidemic SEIR Model. J Clin Med. 2020;9: 944. doi:10.3390/jcm9040944
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.3390/jcm9040944&link_type=DOI)
54. 54.Liu Y, Gayle AA, Wilder-Smith A, Rocklöv J. The reproductive number of COVID-19 is higher compared to SARS coronavirus. J Travel Med. 2020;27: taaa021. doi:10.1093/jtm/taaa021
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1093/jtm/taaa021&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=32052846&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F05%2F31%2F2020.05.23.20111021.atom)
55. 55.Chen H, Xu W, Paris C, Reeson A, Li X. Social distance and SARS memory: impact on the public awareness of 2019 novel coronavirus (COVID-19) outbreak. Infectious Diseases (except HIV/AIDS); 2020 Mar. doi:10.1101/2020.03.11.20033688
[Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NzoibWVkcnhpdiI7czo1OiJyZXNpZCI7czoyMToiMjAyMC4wMy4xMS4yMDAzMzY4OHYxIjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjAvMDUvMzEvMjAyMC4wNS4yMy4yMDExMTAyMS5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=)
56. 56.Chowell G, Abdirizak F, Lee S, Lee J, Jung E, Nishiura H, et al. Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study. BMC Med. 2015;13: 1–12. doi:10.1186/s12916-015-0450-0
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1186/s12916-014-0241-z&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=25563062&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F05%2F31%2F2020.05.23.20111021.atom)
57. 57.Delamater PL, Street EJ, Leslie TF, Yang YT, Jacobsen KH. Complexity of the Basic Reproduction Number (R0). Emerg Infect Dis. 2019;25: 1–4. doi:10.3201/eid2501.171901
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.3201/eid2501.171901&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=30560777&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F05%2F31%2F2020.05.23.20111021.atom)
58. 58., for the Zhongnan Hospital of Wuhan University Novel Coronavirus Management and Research Team, Evidence-Based Medicine Chapter of China International Exchange and Promotive Association for Medical and Health Care (CPAM), Jin Y-H, Cai L, Cheng Z-S, Cheng H, Deng T, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res. 2020;7: 4. doi:10.1186/s40779-020-0233-6
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1186/s40779-020-0233-6&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=32029004&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F05%2F31%2F2020.05.23.20111021.atom)
59. 59.Guerra FM, Bolotin S, Lim G, Heffernan J, Deeks SL, Li Y, et al. The basic reproduction number (R 0) of measles: a systematic review. Lancet Infect Dis. 2017;17: e420–e428. doi:10.1016/S1473-3099(17)30307-9
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/S1473-3099(17)30307-9&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F05%2F31%2F2020.05.23.20111021.atom)
60. 60.Cowling BJ, Ali ST, Ng TWY, Tsang TK, Li JCM, Fong MW, et al. Impact assessment of non-pharmaceutical interventions against COVID-19 and influenza in Hong Kong: an observational study. Epidemiology; 2020 Mar. doi:10.1101/2020.03.12.20034660
[Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NzoibWVkcnhpdiI7czo1OiJyZXNpZCI7czoyMToiMjAyMC4wMy4xMi4yMDAzNDY2MHYxIjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjAvMDUvMzEvMjAyMC4wNS4yMy4yMDExMTAyMS5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=)
61. 61.Lai S, Ruktanonchai NW, Zhou L, Prosper O, Luo W, Floyd JR, et al. Effect of non-pharmaceutical interventions for containing the COVID-19 outbreak in China. Infectious Diseases (except HIV/AIDS); 2020 Mar. doi:10.1101/2020.03.03.20029843
[Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NzoibWVkcnhpdiI7czo1OiJyZXNpZCI7czoyMToiMjAyMC4wMy4wMy4yMDAyOTg0M3YzIjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjAvMDUvMzEvMjAyMC4wNS4yMy4yMDExMTAyMS5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=)
62. 62.Imai N, Gaythorpe KAM, Abbott S, Bhatia S, van Elsland S, Prem K, et al. Adoption and impact of non-pharmaceutical interventions for COVID-19. Wellcome Open Res. 2020;5: 59. doi:10.12688/wellcomeopenres.15808.1
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.12688/wellcomeopenres.15808.1&link_type=DOI)
63. 63.Huedo-Medina TB, Sánchez-Meca J, Marín-Martínez F, Botella J. Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods. 2006;11: 193—206. doi:10.1037/1082-989X.11.2.193
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1037/1082-989X.11.2.193&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=16784338&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F05%2F31%2F2020.05.23.20111021.atom)
[Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000238430400005&link_type=ISI)
64. 64.Wallinga J, Lipsitch M. How generation intervals shape the relationship between growth rates and reproductive numbers. Proc R Soc B Biol Sci. 2007;274: 599–604. doi:10.1098/rspb.2006.3754
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1098/rspb.2006.3754&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=17476782&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F05%2F31%2F2020.05.23.20111021.atom)
[Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000243354200019&link_type=ISI)
65. 65.Svensson Å. A note on generation times in epidemic models. Math Biosci. 2007;208: 300–311. doi:10.1016/j.mbs.2006.10.010
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.mbs.2006.10.010&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=17174352&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F05%2F31%2F2020.05.23.20111021.atom)
[Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000248196400017&link_type=ISI)
66. 66.Vink MA, Bootsma MCJ, Wallinga J. Serial Intervals of Respiratory Infectious Diseases: A Systematic Review and Analysis. Am J Epidemiol. 2014;180: 865–875. doi:10.1093/aje/kwu209
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1093/aje/kwu209&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=25294601&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F05%2F31%2F2020.05.23.20111021.atom)
[Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000344600900001&link_type=ISI)
67. 67.Cowling BJ, Fang VJ, Riley S, Peiris JSM, Leung GM. Estimation of the serial interval of influenza. Epidemiol Camb Mass. 2009;20: 344–347. doi:10.1097/EDE.0b013e31819d1092
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1097/EDE.0b013e31819d1092&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=19279492&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F05%2F31%2F2020.05.23.20111021.atom)
[Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000265199800007&link_type=ISI)